Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-10
SponsorShanghai Eye Disease Prevention and Treatment Center

About this trial

To explore the minimum power and frequency of Repeated Low-level Red-light (RLRL) to control myopia progression in low-myopic children aged 8-10 years, and the rebound effect of low-myopic children after discontinuation of RLRL with different combinations of power and frequency.

Eligibility criteria

Qualifiers

Age: 8-10 years old

Low myopia: cycloplegic spherical equivalent refractions (SERs) range from -0.50 (inclusive) to -3.00 diopters (D) and astigmatism less than -2.5 D in either eye.

signed informed consent and was able to participate in the study

Disqualifiers

Secondary myopia, such as a history of retinopathy of prematurity or other neonatal diseases; syndromic myopia with a known genetic disorder or connective tissue disease, such as Stickler syndrome or Marfan syndrome

Strabismus or other binocular vision abnormalities

Cloudy refractive media: cloudy cornea, cataract or intraocular lens surgery

Eye diseases that affect retinal function: macular degeneration, diabetic retinopathy, retinal detachment, glaucoma or ocular hypertension, endophthalmitis, uveitis, optic neuropathy, etc.

Trial design

Treatments tested in this trial

  • Repeated Low-level Red-light
  • Red LED

Treatment groups

108 Participants
are divided into 9 treatment groups

9

Treatment groups

See each treatment group below.